3122-84-7

Usage

Uses

Used in Pharmaceutical Industry:
4-Chloro-6-(methoxymethyl)pyrimidine(SALTDATA: FREE) is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Production:
In the agrochemical industry, 4-Chloro-6-(methoxymethyl)pyrimidine(SALTDATA: FREE) serves as a building block in the creation of effective and targeted agrochemicals. Its incorporation into these products enhances their performance and contributes to sustainable agricultural practices.
Used in Fine Chemicals Synthesis:
4-Chloro-6-(methoxymethyl)pyrimidine(SALTDATA: FREE) is also utilized in the synthesis of fine chemicals, which are high-purity chemicals used in various applications such as fragrances, dyes, and other specialty chemicals. Its versatility and reactivity make it a valuable component in this field.
Used in Research and Development:
As a compound with unique properties, 4-Chloro-6-(methoxymethyl)pyrimidine(SALTDATA: FREE) is extensively used in research and development applications. It aids scientists in exploring new chemical reactions, understanding molecular interactions, and discovering innovative applications across various industries.

Upstream product

• 3122-78-9 4-methoxymethyl-6-hydroxypyrimidine 
• 41051-15-4 4-methoxyacetoacetic acid methylester 

Downstream Products

• 302964-09-6 6-(methoxymethyl)pyrimidin-4-amine 
• 65934-74-9 3-(trifluoromethyl)-4-methylaniline 
• 1428558-38-6 (6-(3,4-dichlorophenylamino)pyrimidin-4-yl)methanol 
• 1428558-37-5 N-(3,4-dichlorophenyl)-6-(methoxymethyl)pyrimidin-4-amine 

Relevant academic research and scientific papers

Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.

PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.

QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic 7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

Cyclic protein tyrosine kinase inhibitors

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Tyrosine kinase inhibitors

The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

Pyrimidylalkylthio benzimidale compounds, pharmaceutical compositions and use

This invention relates to 2- and 4-pyrimidinylmethylsulphinyl(and thio)benzimidazoles in which the pyrimidyl group is substituted by an optionally substituted amino group. These compounds inhibit exogenously and endogenously stimulated gastric acid secretion.